Comparison of MRI pulse sequences in defining prostate volume after permanent implantation

International Journal of Radiation Oncology Biology Physics

Volumn 54, Issue 3, 2002, Pages 703-711

  McLaughlin, P W ^a   Narayana, V ^a   Drake, D G ^a   Miller, B M ^a   Marsh, L ^b   Chan, J ^c   Gonda Jr , R ^a   Winfield, R J ^a   Roberson, P L ^a  

^a PROVIDENCE HOSPITAL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Postimplant dosimetry; Prostate implant; Prostate MRI; Prostate swelling

Indexed keywords

DOSIMETRY; IMAGING TECHNIQUES; IMPLANTS (SURGICAL); MAGNETIC RESONANCE IMAGING;

FAT SATURATION;

ONCOLOGY;

IODINE 125;

ARTICLE; BLADDER; CLINICAL ARTICLE; CONTROLLED STUDY; EDEMA; HUMAN; IMAGE ANALYSIS; IMAGING SYSTEM; IMPLANTATION; INTERMETHOD COMPARISON; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN SIZE; PRIORITY JOURNAL; PROSTATE; SEMINAL VESICLE; ULTRASOUND; URETHRA;

BRACHYTHERAPY; HUMANS; IODINE RADIOISOTOPES; MAGNETIC RESONANCE IMAGING; MALE; PROSTATE; PROSTATIC NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0036837113     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)02991-7     Document Type: Article

References (44)

1. Nag S., Bice W., deWyngaert K., et al. The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis. Int J Radiat Oncol Biol Phys. 46:2000;221-230.
2. Narayana V., Roberson P.L., Winfield R.J., McLaughlin P.W. Impact of ultrasound and computed tomography prostate volume registration on evaluation of permanent prostate implant. Int J Radiat Oncol Biol Phys. 39:1997;341-346.
3. 125I prostate implants. Int J Radiat Oncol Biol Phys. 34:1996;717-725.
4. Algan O., Hanks G.E., Shaer A.H. Localization of the prostatic apex for radiation treatment planning. Int J Radiat Oncol Biol Phys. 33:1995;925-930.
5. Roach M., Faillace-Akazawa P., Malfatti C., et al. Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys. 35:1996;1011-1018.
6. Milosevic M., Voruganti S., Blend R., et al. Magnetic resonance imaging (MRI) for localization of prostatic apex Comparison to computed tomography (CT) and urethrography . Radiother Oncol. 47:1998;277-284.
7. Rasch C., Barillot I., Remeijer P., et al. Definition of the prostate in CT and MRI A multi-observer study . Int J Radiat Oncol Biol Phys. 43:1999;57-66.
8. Debois M., Oyen R., Maes F., et al. The contribution of magnetic resonance imaging to the three-dimensional treatment planning of localized prostate cancer. Int J Radiat Oncol Biol Phys. 45:1999;857-865.
9. Narayana V., Roberson P.L., Pu A.T., et al. Impact of differences in ultrasound and computed tomography volumes on treatment planning of permanent prostate implants. Int J Radiat Oncol Biol Phys. 37:1997;1181-1185.
10. Prestidge B.R., Bice W.S., Kiefer E.J., et al. Timing of computed tomography-based postimplant assessment following permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 40:1998;1111-1115.
11. Waterman F., Yue N., Cord B.W., et al. Edema associated with I-125 or Pd-103 prostate brachytherapy and its impact on post-implant dosimetry An analysis based on serial CT acquisition . Int J Radiat Oncol Biol Phys. 41:1998;1069-1077.
12. Dubois D.F., Prestidge B.R., Hotchkiss L.A., et al. Intraobserver and interobserver variability of MR imaging and CT-derived prostate volumes after transperineal interstitial permanent prostate brachytherapy. Radiology. 207:1998;785-789.
13. Dubois D.F., Prestidge B.R., Hotchkiss L.A., et al. Source localization following permanent transperineal prostate interstitial brachytherapy using magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 39:1997;1037-1041.
14. Coakley F.V., Hricak H., Wefer A.E., et al. Brachytherapy for prostate cancer Endorectal MR imaging of local treatment-related changes . Radiology. 219:2001;817-821.
15. Amdur R.J., Gladstone D., Leopold K.A., et al. Prostate seed implant quality assessment using MR and CT image fusion. Int J Radiat Oncol Biol Phys. 43:1999;67-72.
16. Tiwari S., Mitra R.K., Horwitz E.M., et al. Evaluation of permanent prostate implants A pilot study comparing dosimetric impact of inter-observer variability using CT and MRI . Int J Radiat Oncol Biol Phys. 51:(Suppl. 1):2001;318.
17. Moerland M.A., Wijrdeman H.K., Beersma R., et al. Evaluation of permanent I-125 prostate implants using radiography and magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 37:1997;927-933.
18. Sidhu S., Morris W.J., Spadinger I., et al. Prostate brachytherapy post-implant dosimetry A comparison of prostate quadrants . [Abstract] American Brachytherapy Society Proceedings. 2001.
19. Merrick G.S., Butler W.M., Dorsey A.T., et al. The dependence of prostate postimplant dosimetric quality on CT volume determination. Int J Radiat Oncol Biol Phys. 44:1999;1111-1117.
20. Merrick G.S., Butler W.M., Galbreath R.W., et al. Five-year biochemical outcome following permanent interstitial brachytherapy for clinical T1-T3 prostate cancer. Int J Radiat Oncol Biol Phys. 51:2001;41-48.
21. 125I brachytherapy. Int J Radiat Oncol Biol Phys. 51:2001;31-40.
22. Potters L. Permanent prostate brachytherapy Lessons learned, lessons to learn . Oncology. 14:2000;1219-1220.
23. Krupski T., Petroni G.R., Bissonette E.A., et al. Quality-of-life comparison of radical prostatectomy and interstitial brachytherapy in the treatment of clinically localized prostate cancer. Urology. 55:2000;736-742.
24. Brandeis J.M., Litwin M.S., Burnison C.M., et al. Quality of life outcomes after brachytherapy for early stage prostate cancer. J Urol. 163:2000;851-857.
25. Lee W.R., McQuellon R.P., Harris-Henderson K., et al. A preliminary analysis of health-related quality of life in the first year after permanent source interstitial brachytherapy (PIB) for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 46:2000;77-81.
26. Arterbery V.E., Frazier A., Dalmia P., et al. Quality of life after permanent prostate implant. Semin Surg Oncol. 13:1997;461-464.
27. Wei JT, Dunn RL, Sandler HM, et al. A comprehensive comparison of health related quality of life following contemporary therapies for localized prostate cancer. J Clin Oncol. In press.
28. Lee W.R., Hall M.C., McQuellon R.P., et al. A prospective quality-of-life studying men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy. Int J Radiat Oncol Biol Phys. 51:2001;614-623.
29. Gelblum D.Y., Potters L., Ashley R., et al. Urinary morbidity following ultrasound-guided transperineal prostate seed implantation. Int J Radiat Oncol Biol Phys. 45:1999;59-67.
30. Merrick G.S., Butler W.M., Lief J.H., et al. Temporal resolution of urinary morbidity following prostate brachytherapy. Int J Radiat Oncol Biol Phys. 47:2000;121-128.
31. Desai J., Stock R.G., Stone N.N., et al. Acute urinary morbidity following I-125 interstitial implantation of the prostate gland. Radiat Oncol Invest. 6:1998;135-141.
32. Gelblum D.Y., Potters L., Ashley R., et al. Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 48:2000;119-124.
33. Thomas M.D., Cormack R., Tempany C.M., et al. Identifying the predictors of acute urinary retention following magnetic-resonance-guided prostate brachytherapy. Int J Radiat Oncol Biol Phys. 47:2001;905-908.
34. Merrick G.S., Butler W.M., Galbreath R.W., et al. Relationship between the transition zone index of the prostate gland and urinary morbidity after brachytherapy. Urology. 57:2001;524-529.
35. Merrick G.S., Wallner K., Butler W.M., et al. Short-term sexual function after brachytherapy. Int J Cancer. 96:2001;313-319.
36. Merrick G.S., Wallner K., Butler W.M., et al. A comparison of radiation dose to the bulb of the penis in men with and without prostate brachytherapy-induced erectile dysfunction. Int J Radiat Oncol Biol Phys. 50:2001;597-604.
37. 103Pd brachytherapy and external beam irradiation for clinical localized, high-risk prostatic carcinoma. Int J Radiat Oncol Biol Phys. 35:1996;875-879.
38. D'Amico A.V., Davis A., Vargas S.O., et al. Defining the implant treatment volume for patients with low risk prostate cancer Does the anterior base need to be treated? Int J Radiat Oncol Biol Phys. 43:1999;587-590.
39. Zaider M., Zelefsky M.J., Lee E.K., et al. Treatment planning for prostate implants using magnetic-resonance spectroscopy imaging. Int J Radiat Oncol Biol Phys. 47:2000;1085-1096.
40. Zelefsky M.J., Cohen G., Zakian K.L., et al. Intraoperative conformal optimization for transperineal prostate implants using magnetic resonance spectroscopic imaging. Cancer J. 6:2000;249-255.
41. Hurwitz M.D., Cormack R., Tempany C.M., et al. Three-dimensional real-time magnetic resonance-guided interstitial prostate brachytherapy optimized radiation dose distribution resulting in a favorable acute side effect profile in patients with clinically localized prostate cancer. Techniques Urol. 6:2000;89-94.
42. 125I prostate implants using interventional magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 45:2000;207-214.
43. Roberson P.L., Narayana V., McShan D.L., et al. Source placement error for permanent implant of the prostate. Med Phys. 24:1997;251-257.
44. McLaughlin P.W., Narayana V., Dworzanin M.E., et al. Permanent implantation of 125-I sources in the prostate Radical limits of simplicity . Radiology. 213:1999;839-844.